TCL Archive Rep. Bliley Challenges FDA On Failure To Approve Oral Colon Cancer Drug UFT. April 21, 2000
TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive University of Wisconsin wins $7 million NIH construction grant for cancer center. June 25, 2004
TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
